Literature DB >> 32425183

[Managing cardiac patients post-COVID-19 pandemic: a proposal by the ANMCO Veneto Region].

Claudio Bilato1, Loris Roncon2, Maurizio Anselmi3, Roberto Valle4, Cosimo Perrone1, Alessandro Mecenero1, Marco Zuin2, Sakis Themistoclakis5.   

Abstract

The COVID-19 post-lockdown period and the subsequent progressive withdrawal of the quarantine measures are currently allowing the gradual resumption of the ordinary clinical activities, which have been suppressed during the COVID-19 pandemic. In this phase, it is crucial to minimize the risk of infection to limit COVID-19-related morbidity and mortality and the number of new cases. Indeed, COVID-19 manifestations may be equivocal, including asymptomatic or mildly symptomatic patients. In order to ensure the safety of patients and healthcare providers, therefore, it is mandatory to stratify the risk of post-COVID-19 pandemic infection during the clinical and instrumental evaluation of cardiac patients, who are at low risk for COVID-19. Here we discuss the most common diagnostic procedures and therapeutic activities, the type of personal protective equipment according to the different tests, the timetable of the different diagnostic examinations, the tele-health services or alternative strategies, and the structural and management requirements, that should be applied to protect patients and healthcare providers in the post-COVID-19 era.

Entities:  

Mesh:

Year:  2020        PMID: 32425183     DOI: 10.1714/3359.33322

Source DB:  PubMed          Journal:  G Ital Cardiol (Rome)        ISSN: 1827-6806


  2 in total

1.  Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.

Authors:  Simone Saibeni; Ludovica Scucchi; Gabriele Dragoni; Cristina Bezzio; Agnese Miranda; Davide Giuseppe Ribaldone; Angela Bertani; Fabrizio Bossa; Mariangela Allocca; Andrea Buda; Gianmarco Mocci; Alessandra Soriano; Silvia Mazzuoli; Lorenzo Bertani; Flavia Baccini; Erika Loddo; Antonino Carlo Privitera; Alessandro Sartini; Angelo Viscido; Laurino Grossi; Valentina Casini; Viviana Gerardi; Marta Ascolani; Mirko Di Ruscio; Giovanni Casella; Edoardo Savarino; Davide Stradella; Rossella Pumpo; Claudio Camillo Cortelezzi; Marco Daperno; Valeria Ciardo; Olga Maria Nardone; Flavio Caprioli; Giovanna Vitale; Maria Cappello; Michele Comberlato; Patrizia Alvisi; Stefano Festa; Michele Campigotto; Giorgia Bodini; Paola Balestrieri; Anna Viola; Daniela Pugliese; Alessandro Armuzzi; Massimo C Fantini; Gionata Fiorino
Journal:  United European Gastroenterol J       Date:  2020-10-18       Impact factor: 4.623

Review 2.  Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.

Authors:  Marko Kumric; Tina Ticinovic Kurir; Dinko Martinovic; Piero Marin Zivkovic; Josko Bozic
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.